APO Research
Talk to an analyst

APO RESEARCH · REPORT

Corneal Graft Rejection Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Corneal Graft Rejection Drug Industry Growth and Trends Forecast to 2032

19 December 202575 pages

Choose your research edition.

Industry ResearchCorneal Graft Rejection Drug Industry Research Report 2026106 pages · $2,950 USDIndustry Growth & TrendsGlobal Corneal Graft Rejection Drug Industry Growth and Trends Forecast to 203275 pages · $3,450 USDMarket StructureGlobal Corneal Graft Rejection Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032174 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Corneal Graft Rejection Drug Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Corneal Graft Rejection Drug Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Corneal Graft Rejection Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Corneal Graft Rejection Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Corneal Graft Rejection Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Corneal Graft Rejection Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Corneal Graft Rejection Drug include Circadian Technologies Limited, Gene Signal International SA, Oxford BioMedica Plc and Santen Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Corneal Graft Rejection Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Corneal Graft Rejection Drug market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Corneal Graft Rejection Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Corneal Graft Rejection Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Corneal Graft Rejection Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Corneal Graft Rejection Drug Market by Company

Circadian Technologies Limited

Gene Signal International SA

Oxford BioMedica Plc

Santen Pharmaceutical Co., Ltd.

Corneal Graft Rejection Drug Segment by Type

VGX-100

OXB-202

GB-301

Cyndacel-M

Others

Corneal Graft Rejection Drug Segment by Application

Hospital

Clinic

Others

Corneal Graft Rejection Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Corneal Graft Rejection Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Corneal Graft Rejection Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Corneal Graft Rejection Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Corneal Graft Rejection Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Corneal Graft Rejection Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of VGX-100 Table 2. Major Company of OXB-202 Table 3. Major Company of GB-301 Table 4. Major Company of Cyndacel-M Table 5. Major Company of Others Table 6. Global Corneal Graft Rejection Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Corneal Graft Rejection Drug Sales by Type (2021-2026) & (K Units) Table 8. Global Corneal Graft Rejection Drug Sales Market Share in Volume by Type (2021-2026) Table 9. Global Corneal Graft Rejection Drug Sales by Type (2021-2026) & (US$ Million) Table 10. Global Corneal Graft Rejection Drug Sales Market Share in Value by Type (2021-2026) Table 11. Global Corneal Graft Rejection Drug Price by Type (2021-2026) & (US$/Unit) Table 12. Global Corneal Graft Rejection Drug Sales by Type (2027-2032) & (K Units) Table 13. Global Corneal Graft Rejection Drug Sales Market Share in Volume by Type (2027-2032) Table 14. Global Corneal Graft Rejection Drug Sales by Type (2027-2032) & (US$ Million) Table 15. Global Corneal Graft Rejection Drug Sales Market Share in Value by Type (2027-2032) Table 16. Global Corneal Graft Rejection Drug Price by Type (2027-2032) & (US$/Unit) Table 17. North America Corneal Graft Rejection Drug Sales by Type (2021-2026) & (K Units) Table 18. North America Corneal Graft Rejection Drug Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Corneal Graft Rejection Drug Sales by Type (2021-2026) & (K Units) Table 20. Europe Corneal Graft Rejection Drug Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Corneal Graft Rejection Drug Sales by Type (2021-2026) & (K Units) Table 22. Asia-Pacific Corneal Graft Rejection Drug Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Corneal Graft Rejection Drug Sales by Type (2021-2026) & (K Units) Table 24. Latin America Corneal Graft Rejection Drug Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Corneal Graft Rejection Drug Sales by Type (2021-2026) & (K Units) Table 26. Middle East and Africa Corneal Graft Rejection Drug Sales by Type (2021-2026) & (US$ Million) Table 27. Corneal Graft Rejection Drug Industry Trends Table 28. Corneal Graft Rejection Drug Industry Drivers Table 29. Corneal Graft Rejection Drug Industry Opportunities and Challenges Table 30. Corneal Graft Rejection Drug Industry Restraints Table 31. Global Corneal Graft Rejection Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Corneal Graft Rejection Drug Revenue Market Share by Company (2021-2026) Table 33. Global Corneal Graft Rejection Drug Sales by Company (2021-2026) & (K Units) Table 34. Global Corneal Graft Rejection Drug Sales Share by Company (2021-2026) Table 35. Global Corneal Graft Rejection Drug Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global Corneal Graft Rejection Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Corneal Graft Rejection Drug Major Company Production Sites and Headquarters Table 38. Global Corneal Graft Rejection Drug Company, Product Type & Application Table 39. Global Corneal Graft Rejection Drug Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Corneal Graft Rejection Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Corneal Graft Rejection Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Corneal Graft Rejection Drug Sales by Region (2021-2026) & (K Units) Table 44. Global Corneal Graft Rejection Drug Sales Market Share in Volume by Region (2021-2026) Table 45. Global Corneal Graft Rejection Drug Sales by Region (2021-2026) & (US$ Million) Table 46. Global Corneal Graft Rejection Drug Sales Market Share in Value by Region (2021-2026) Table 47. Global Corneal Graft Rejection Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global Corneal Graft Rejection Drug Sales by Region (2027-2032) & (K Units) Table 49. Global Corneal Graft Rejection Drug Sales Market Share in Volume by Region (2027-2032) Table 50. Global Corneal Graft Rejection Drug Sales by Region (2027-2032) & (US$ Million) Table 51. Global Corneal Graft Rejection Drug Sales Market Share in Value by Region (2027-2032) Table 52. Global Corneal Graft Rejection Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global Corneal Graft Rejection Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Corneal Graft Rejection Drug Sales by Application (2021-2026) & (K Units) Table 55. Global Corneal Graft Rejection Drug Sales Market Share in Volume by Application (2021-2026) Table 56. Global Corneal Graft Rejection Drug Sales by Application (2021-2026) & (US$ Million) Table 57. Global Corneal Graft Rejection Drug Sales Market Share in Value by Application (2021-2026) Table 58. Global Corneal Graft Rejection Drug Price by Application (2021-2026) & (US$/Unit) Table 59. Global Corneal Graft Rejection Drug Sales by Application (2027-2032) & (K Units) Table 60. Global Corneal Graft Rejection Drug Sales Market Share in Volume by Application (2027-2032) Table 61. Global Corneal Graft Rejection Drug Sales by Application (2027-2032) & (US$ Million) Table 62. Global Corneal Graft Rejection Drug Sales Market Share in Value by Application (2027-2032) Table 63. Global Corneal Graft Rejection Drug Price by Application (2027-2032) & (US$/Unit) Table 64. North America Corneal Graft Rejection Drug Sales by Application (2021-2026) & (K Units) Table 65. North America Corneal Graft Rejection Drug Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Corneal Graft Rejection Drug Sales by Application (2021-2026) & (K Units) Table 67. Europe Corneal Graft Rejection Drug Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Corneal Graft Rejection Drug Sales by Application (2021-2026) & (K Units) Table 69. Asia-Pacific Corneal Graft Rejection Drug Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Corneal Graft Rejection Drug Sales by Application (2021-2026) & (K Units) Table 71. Latin America Corneal Graft Rejection Drug Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Corneal Graft Rejection Drug Sales by Application (2021-2026) & (K Units) Table 73. Middle East and Africa Corneal Graft Rejection Drug Sales by Application (2021-2026) & (US$ Million) Table 74. Circadian Technologies Limited Company Information Table 75. Circadian Technologies Limited Business Overview Table 76. Circadian Technologies Limited Corneal Graft Rejection Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Circadian Technologies Limited Corneal Graft Rejection Drug Product Portfolio Table 78. Circadian Technologies Limited Recent Development Table 79. Gene Signal International SA Company Information Table 80. Gene Signal International SA Business Overview Table 81. Gene Signal International SA Corneal Graft Rejection Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Gene Signal International SA Corneal Graft Rejection Drug Product Portfolio Table 83. Gene Signal International SA Recent Development Table 84. Oxford BioMedica Plc Company Information Table 85. Oxford BioMedica Plc Business Overview Table 86. Oxford BioMedica Plc Corneal Graft Rejection Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Oxford BioMedica Plc Corneal Graft Rejection Drug Product Portfolio Table 88. Oxford BioMedica Plc Recent Development Table 89. Santen Pharmaceutical Co., Ltd. Company Information Table 90. Santen Pharmaceutical Co., Ltd. Business Overview Table 91. Santen Pharmaceutical Co., Ltd. Corneal Graft Rejection Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Santen Pharmaceutical Co., Ltd. Corneal Graft Rejection Drug Product Portfolio Table 93. Santen Pharmaceutical Co., Ltd. Recent Development Table 94. North America Corneal Graft Rejection Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 95. North America Corneal Graft Rejection Drug Sales by Country (2021-2026) & (K Units) Table 96. North America Corneal Graft Rejection Drug Sales Market Share by Country (2021-2026) Table 97. North America Corneal Graft Rejection Drug Sales Forecast by Country (2027-2032) & (K Units) Table 98. North America Corneal Graft Rejection Drug Sales Market Share Forecast by Country (2027-2032) Table 99. North America Corneal Graft Rejection Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 100. North America Corneal Graft Rejection Drug Market Size by Country (2021-2026) & (US$ Million) Table 101. North America Corneal Graft Rejection Drug Market Share by Country (2021-2026) Table 102. North America Corneal Graft Rejection Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 103. North America Corneal Graft Rejection Drug Market Share Forecast by Country (2027-2032) Table 104. Europe Corneal Graft Rejection Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 105. Europe Corneal Graft Rejection Drug Sales by Country (2021-2026) & (K Units) Table 106. Europe Corneal Graft Rejection Drug Sales Market Share by Country (2021-2026) Table 107. Europe Corneal Graft Rejection Drug Sales Forecast by Country (2027-2032) & (K Units) Table 108. Europe Corneal Graft Rejection Drug Sales Market Share Forecast by Country (2027-2032) Table 109. Europe Corneal Graft Rejection Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 110. Europe Corneal Graft Rejection Drug Market Size by Country (2021-2026) & (US$ Million) Table 111. Europe Corneal Graft Rejection Drug Market Share by Country (2021-2026) Table 112. Europe Corneal Graft Rejection Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 113. Europe Corneal Graft Rejection Drug Market Share Forecast by Country (2027-2032) Table 114. Asia-Pacific Corneal Graft Rejection Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 115. Asia-Pacific Corneal Graft Rejection Drug Sales by Country (2021-2026) & (K Units) Table 116. Asia-Pacific Corneal Graft Rejection Drug Sales Market Share by Country (2021-2026) Table 117. Asia-Pacific Corneal Graft Rejection Drug Sales Forecast by Country (2027-2032) & (K Units) Table 118. Asia-Pacific Corneal Graft Rejection Drug Sales Market Share Forecast by Country (2027-2032) Table 119. Asia-Pacific Corneal Graft Rejection Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 120. Asia-Pacific Corneal Graft Rejection Drug Market Size by Country (2021-2026) & (US$ Million) Table 121. Asia-Pacific Corneal Graft Rejection Drug Market Share by Country (2021-2026) Table 122. Asia-Pacific Corneal Graft Rejection Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 123. Asia-Pacific Corneal Graft Rejection Drug Market Share Forecast by Country (2027-2032) Table 124. Latin America Corneal Graft Rejection Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 125. Latin America Corneal Graft Rejection Drug Sales by Country (2021-2026) & (K Units) Table 126. Latin America Corneal Graft Rejection Drug Sales Market Share by Country (2021-2026) Table 127. Latin America Corneal Graft Rejection Drug Sales Forecast by Country (2027-2032) & (K Units) Table 128. Latin America Corneal Graft Rejection Drug Sales Market Share Forecast by Country (2027-2032) Table 129. Latin America Corneal Graft Rejection Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 130. Latin America Corneal Graft Rejection Drug Market Size by Country (2021-2026) & (US$ Million) Table 131. Latin America Corneal Graft Rejection Drug Market Share by Country (2021-2026) Table 132. Latin America Corneal Graft Rejection Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 133. Latin America Corneal Graft Rejection Drug Market Share Forecast by Country (2027-2032) Table 134. Middle East and Africa Corneal Graft Rejection Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 135. Middle East and Africa Corneal Graft Rejection Drug Sales by Country (2021-2026) & (K Units) Table 136. Middle East and Africa Corneal Graft Rejection Drug Sales Market Share by Country (2021-2026) Table 137. Middle East and Africa Corneal Graft Rejection Drug Sales Forecast by Country (2027-2032) & (K Units) Table 138. Middle East and Africa Corneal Graft Rejection Drug Sales Market Share Forecast by Country (2027-2032) Table 139. Middle East and Africa Corneal Graft Rejection Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 140. Middle East and Africa Corneal Graft Rejection Drug Market Size by Country (2021-2026) & (US$ Million) Table 141. Middle East and Africa Corneal Graft Rejection Drug Market Share by Country (2021-2026) Table 142. Middle East and Africa Corneal Graft Rejection Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 143. Middle East and Africa Corneal Graft Rejection Drug Market Share Forecast by Country (2027-2032) Table 144. Key Raw Materials Table 145. Raw Materials Key Suppliers Table 146. Corneal Graft Rejection Drug Distributors List Table 147. Corneal Graft Rejection Drug Customers List Table 148. Research Programs/Design for This Report Table 149. Authors List of This Report Table 150. Secondary Sources Table 151. Primary Sources List of Figures Figure 1. Corneal Graft Rejection Drug Image Figure 2. Global Corneal Graft Rejection Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Corneal Graft Rejection Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Corneal Graft Rejection Drug Sales (2021-2032) & (K Units) Figure 5. VGX-100 Image Figure 6. Global VGX-100 Sales YoY Growth (2021-2032) & (K Units) Figure 7. OXB-202 Image Figure 8. Global OXB-202 Sales YoY Growth (2021-2032) & (K Units) Figure 9. GB-301 Image Figure 10. Global GB-301 Sales YoY Growth (2021-2032) & (K Units) Figure 11. Cyndacel-M Image Figure 12. Global Cyndacel-M Sales YoY Growth (2021-2032) & (K Units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 15. Global Corneal Graft Rejection Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Corneal Graft Rejection Drug Market Share by Type 2025 VS 2032 Figure 17. North America Corneal Graft Rejection Drug Sales Market Share in Volume by Type in 2025 Figure 18. North America Corneal Graft Rejection Drug Sales Market Share in Value by Type in 2025 Figure 19. Europe Corneal Graft Rejection Drug Sales Market Share in Volume by Type in 2025 Figure 20. Europe Corneal Graft Rejection Drug Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Corneal Graft Rejection Drug Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Corneal Graft Rejection Drug Sales Market Share in Value by Type in 2025 Figure 23. Latin America Corneal Graft Rejection Drug Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Corneal Graft Rejection Drug Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Corneal Graft Rejection Drug Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Corneal Graft Rejection Drug Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Corneal Graft Rejection Drug Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Hospital Image Figure 30. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 31. Clinic Image Figure 32. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 35. Global Corneal Graft Rejection Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Corneal Graft Rejection Drug Market Share by Application 2025 VS 2032 Figure 37. North America Corneal Graft Rejection Drug Sales Market Share in Volume by Application in 2025 Figure 38. North America Corneal Graft Rejection Drug Sales Market Share in Value by Application in 2025 Figure 39. Europe Corneal Graft Rejection Drug Sales Market Share in Volume by Application in 2025 Figure 40. Europe Corneal Graft Rejection Drug Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Corneal Graft Rejection Drug Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Corneal Graft Rejection Drug Sales Market Share in Value by Application in 2025 Figure 43. Latin America Corneal Graft Rejection Drug Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Corneal Graft Rejection Drug Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Corneal Graft Rejection Drug Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Corneal Graft Rejection Drug Sales Market Share in Value by Application in 2025 Figure 47. North America Corneal Graft Rejection Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. North America Corneal Graft Rejection Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Corneal Graft Rejection Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Corneal Graft Rejection Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Corneal Graft Rejection Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Europe Corneal Graft Rejection Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Corneal Graft Rejection Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Corneal Graft Rejection Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Corneal Graft Rejection Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Asia-Pacific Corneal Graft Rejection Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Corneal Graft Rejection Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Corneal Graft Rejection Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Corneal Graft Rejection Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Latin America Corneal Graft Rejection Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Corneal Graft Rejection Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Corneal Graft Rejection Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Corneal Graft Rejection Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Middle East and Africa Corneal Graft Rejection Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Corneal Graft Rejection Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Corneal Graft Rejection Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Corneal Graft Rejection Drug Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Corneal Graft Rejection Drug Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • VGX-100
  • OXB-202
  • GB-301
  • Cyndacel-M
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Circadian Technologies Limited
  • Gene Signal International SA
  • Oxford BioMedica Plc
  • Santen Pharmaceutical Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Corneal Graft Rejection Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Corneal Graft Rejection Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Corneal Graft Rejection Drug Market by Type
  6. 1.3.1 VGX-100
  7. 1.3.2 OXB-202
  8. 1.3.3 GB-301
  9. 1.3.4 Cyndacel-M
  10. 1.3.5 Others
  11. 1.4 Global Corneal Graft Rejection Drug Market Size by Type
  12. 1.4.1 Global Corneal Graft Rejection Drug Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Corneal Graft Rejection Drug Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Corneal Graft Rejection Drug Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Corneal Graft Rejection Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Corneal Graft Rejection Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Corneal Graft Rejection Drug Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Corneal Graft Rejection Drug Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Corneal Graft Rejection Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Corneal Graft Rejection Drug Industry Trends
  2. 2.2 Corneal Graft Rejection Drug Industry Drivers
  3. 2.3 Corneal Graft Rejection Drug Industry Opportunities and Challenges
  4. 2.4 Corneal Graft Rejection Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Corneal Graft Rejection Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Corneal Graft Rejection Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Corneal Graft Rejection Drug Price (2021-2026)
  4. 3.4 Global Corneal Graft Rejection Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Corneal Graft Rejection Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Corneal Graft Rejection Drug Company, Product Type & Application
  7. 3.7 Global Corneal Graft Rejection Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Corneal Graft Rejection Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Corneal Graft Rejection Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Corneal Graft Rejection Drug Tier 1, Tier 2, and Tier 3
4 Corneal Graft Rejection Drug Regional Status and Outlook
  1. 4.1 Global Corneal Graft Rejection Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Corneal Graft Rejection Drug Historic Market Size by Region
  3. 4.2.1 Global Corneal Graft Rejection Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Corneal Graft Rejection Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Corneal Graft Rejection Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Corneal Graft Rejection Drug Forecasted Market Size by Region
  7. 4.3.1 Global Corneal Graft Rejection Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Corneal Graft Rejection Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Corneal Graft Rejection Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Corneal Graft Rejection Drug by Application
  1. 5.1 Corneal Graft Rejection Drug Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Corneal Graft Rejection Drug Market Size by Application
  6. 5.2.1 Global Corneal Graft Rejection Drug Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Corneal Graft Rejection Drug Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Corneal Graft Rejection Drug Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Corneal Graft Rejection Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Corneal Graft Rejection Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Corneal Graft Rejection Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Corneal Graft Rejection Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Corneal Graft Rejection Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Circadian Technologies Limited
  2. 6.1.1 Circadian Technologies Limited Company Information
  3. 6.1.2 Circadian Technologies Limited Business Overview
  4. 6.1.3 Circadian Technologies Limited Corneal Graft Rejection Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Circadian Technologies Limited Corneal Graft Rejection Drug Product Portfolio
  6. 6.1.5 Circadian Technologies Limited Recent Developments
  7. 6.2 Gene Signal International SA
  8. 6.2.1 Gene Signal International SA Company Information
  9. 6.2.2 Gene Signal International SA Business Overview
  10. 6.2.3 Gene Signal International SA Corneal Graft Rejection Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Gene Signal International SA Corneal Graft Rejection Drug Product Portfolio
  12. 6.2.5 Gene Signal International SA Recent Developments
  13. 6.3 Oxford BioMedica Plc
  14. 6.3.1 Oxford BioMedica Plc Company Information
  15. 6.3.2 Oxford BioMedica Plc Business Overview
  16. 6.3.3 Oxford BioMedica Plc Corneal Graft Rejection Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Oxford BioMedica Plc Corneal Graft Rejection Drug Product Portfolio
  18. 6.3.5 Oxford BioMedica Plc Recent Developments
  19. 6.4 Santen Pharmaceutical Co., Ltd.
  20. 6.4.1 Santen Pharmaceutical Co., Ltd. Company Information
  21. 6.4.2 Santen Pharmaceutical Co., Ltd. Business Overview
  22. 6.4.3 Santen Pharmaceutical Co., Ltd. Corneal Graft Rejection Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Santen Pharmaceutical Co., Ltd. Corneal Graft Rejection Drug Product Portfolio
  24. 6.4.5 Santen Pharmaceutical Co., Ltd. Recent Developments
7 North America by Country
  1. 7.1 North America Corneal Graft Rejection Drug Sales by Country
  2. 7.1.1 North America Corneal Graft Rejection Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Corneal Graft Rejection Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Corneal Graft Rejection Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Corneal Graft Rejection Drug Market Size by Country
  6. 7.2.1 North America Corneal Graft Rejection Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Corneal Graft Rejection Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Corneal Graft Rejection Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Corneal Graft Rejection Drug Sales by Country
  2. 8.1.1 Europe Corneal Graft Rejection Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Corneal Graft Rejection Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Corneal Graft Rejection Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Corneal Graft Rejection Drug Market Size by Country
  6. 8.2.1 Europe Corneal Graft Rejection Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Corneal Graft Rejection Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Corneal Graft Rejection Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Corneal Graft Rejection Drug Sales by Country
  2. 9.1.1 Asia-Pacific Corneal Graft Rejection Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Corneal Graft Rejection Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Corneal Graft Rejection Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Corneal Graft Rejection Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Corneal Graft Rejection Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Corneal Graft Rejection Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Corneal Graft Rejection Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Corneal Graft Rejection Drug Sales by Country
  2. 10.1.1 South America Corneal Graft Rejection Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Corneal Graft Rejection Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Corneal Graft Rejection Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Corneal Graft Rejection Drug Market Size by Country
  6. 10.2.1 South America Corneal Graft Rejection Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Corneal Graft Rejection Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Corneal Graft Rejection Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Corneal Graft Rejection Drug Sales by Country
  2. 11.1.1 Middle East and Africa Corneal Graft Rejection Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Corneal Graft Rejection Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Corneal Graft Rejection Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Corneal Graft Rejection Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Corneal Graft Rejection Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Corneal Graft Rejection Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Corneal Graft Rejection Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Corneal Graft Rejection Drug Value Chain Analysis
  2. 12.1.1 Corneal Graft Rejection Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Corneal Graft Rejection Drug Production Mode & Process
  7. 12.2 Corneal Graft Rejection Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Corneal Graft Rejection Drug Distributors
  10. 12.2.3 Corneal Graft Rejection Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst